Metoprolol Tartrate Injection USP 1 mg (Metoprolol Tartrate SOLUTION) 1 MG

Metoprolol Tartrate Injection USP 1 MG is a beta-blocker solution used for various cardiovascular conditions. This intravenous formulation is designed for precise administration and rapid onset. Learn more about its uses and effects.

Strength

1 MG

Pack Size

5ML

Manufacturer / TM Owner

SANDOZ CANADA INCORPORATED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Metoprolol Tartrate Injection USP 1 MG is commonly used to manage conditions like high blood pressure, angina, and certain heart rhythm disorders. It works by blocking beta-adrenergic receptors, which can help reduce heart rate and blood pressure. This medication is often administered in clinical settings where immediate effects are required.

Side Effects

Common effects of Metoprolol Tartrate Injection USP 1 MG may include a reduction in heart rate and blood pressure. Some individuals might experience side effects such as dizziness, fatigue, or low blood pressure. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

Metoprolol Tartrate Injection USP 1 MG should be handled with care, ensuring it is stored and administered correctly. It is important to follow medical guidelines for use, especially in patients with certain heart conditions or allergies. Always inform healthcare providers about any existing medical conditions.

Avoid Interactions

Metoprolol Tartrate Injection USP 1 MG may interact with other medications, including certain blood pressure drugs, heart rhythm medications, and some antidepressants. It is also advisable to avoid alcohol while using this medication, as it can enhance certain effects. Always consult a healthcare provider for specific interactions.

Frequently Asked Questions

Metoprolol Tartrate Injection USP 1 MG is used to manage conditions like high blood pressure, angina, and certain heart rhythm disorders.

Metoprolol Tartrate Injection USP 1 MG is administered intravenously, typically in a clinical setting.

Common side effects may include dizziness, fatigue, and low blood pressure.

Metoprolol Tartrate Injection USP 1 MG may interact with other medications, so it is important to consult a healthcare provider.

Metoprolol Tartrate Injection USP 1 MG should be used with caution in patients with certain heart conditions or allergies.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.